progastrin releasing peptide pro-gastrin releasing peptide - ProGRP blood test pro-gastrin Progastrin-Releasing Peptide: A Crucial Biomarker in Clinical Diagnosis

ProGRP Progastrin-releasing peptide (proGRP) has emerged as a significant molecule in the field of medical diagnostics, particularly for its role as a tumor marker作者：G Begolli·2025·被引用次数：2—Conclusions: Concentrations of proGRP in pneumonia and COPD patients were higher than in patients in the ADC and SQCC early stages and could .... This peptide is intricately involved in the physiological processes of the body and has demonstrated considerable utility in the identification and monitoring of certain diseases. Understanding the nature of pro-gastrin releasing peptide and its clinical applications is vital for healthcare professionals and patients alike.

Pro-gastrin-releasing peptide is the precursor to gastrin-releasing peptide (GRP), a neuropeptide that plays a crucial role in various biological functions. GRP, a regulatory molecule encoded by the GRP gene in humans, is a neuropeptide secreted by cells of neural and endocrine origins. It is known to stimulate the secretion of gastrin, thereby influencing gastric acid production.Pro-GRP can be used to support the diagnosis of small cell lung carcinoma (SCLC). Histopathology from biopsy or cytology remains the gold standard for ... The pro-gastrin releasing peptide itself is a polypeptide composed of 125 amino acids. While its physiological functions are still being fully elucidated, its significance largely stems from its association with specific disease states.

One of the most prominent applications of proGRP is its utilization as a biomarker for small cell lung cancer (SCLC). Numerous studies have highlighted the effectiveness of pro-gastrin releasing peptide in the diagnosis of SCLC. For instance, research published in journals like *PubMed* and *PMC* by authors such as HJ Oh and B Nisman, has consistently indicated that pro-gastrin releasing peptide is a sensitive and specific marker for SCLC, often outperforming other established tumor markers like neuron-specific enolase (NSE) and CYFRA 21-1. Reports suggest that pro-gastrin releasing peptide levels can be elevated in patients with SCLC, making it a valuable tool for early detection and diagnosis. The utility of Pro-gastrin releasing peptide extends to supporting the diagnosis of small cell lung carcinoma (SCLC), although histopathology from biopsy or cytology remains the gold standard for definitive diagnosisPro Gastrin Releasing Peptide (ProGRP) - K-Lab.

Beyond SCLC, pro-gastrin releasing peptide has also shown promise in the evaluation of other conditions. Research has explored its potential role in differentiating between benign and malignant diseases, as well as its association with other types of lung cancer, including non-small cell lung cancer (NSCLC). Studies have indicated that pro-gastrin releasing peptide levels can be elevated in a variety of benign and malignant diseases, suggesting its presence as a putative marker beyond just SCLC作者：E Wojcik·2017·被引用次数：83—Pro-gastrin-releasing peptide(ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response .... Furthermore, investigations into serum progastrin-releasing peptide concentrations in conditions like pneumonia and chronic obstructive pulmonary disease (COPD) have shown higher levels in these patients compared to early stages of some lung cancers, prompting further research into its broader diagnostic scope.作者：B Nisman·2016·被引用次数：33—Progastrin-releasing peptide(ProGRP) is a potential marker for small-cell lung cancer (SCLC) in serum; however, it may be more stable in ... The Pro-gastrin releasing peptide may offer insights into the progression and staging of SCLC, with studies noting its correlation with tumor extension.作者：Z Gong·2016·被引用次数：21—ProGRP is a signalpeptidethat is commonly produced by SCLC. Serum ProGRP is considered to be a sensitive tumor biomarker for SCLC.

The assessment of progastrin releasing peptide typically involves blood testsSerum progastrin-releasing peptide in pneumonia, chronic .... The measurement of ProGRP blood test results can provide crucial information for clinicians.pro-Gastrin-Releasing Peptide (pro-GRP) While a specific "Pro GRP normal range" can vary slightly between laboratories and assays, elevated levels are often indicative of underlying pathological processesThe serumpro-gastrin-releasing peptide(ProGRP) levels were increased in a variety of benign and malignant diseases and were considered a putative marker for .... For example, in the context of lung cancer, normal reference values are generally quite low, and significant increases are observed in SCLC. Some studies present median concentrations in benign conditions, other malignancies, or NSCLC as significantly lower (e作者：LE Schonebaum·被引用次数：5—Abstract. Background: Calcitonin (CT), a well-established tumor marker for medullary thyroid carcinoma (MTC), is limited by a high rate of false ....g., around 38-40 pg/mL on the Elecsys® platform) compared to more chronic kidney diseases, where concentrations can be higher (>100 pg/mL).

The development of advanced diagnostic tools, such as the Elecsys® system, aims to improve the accuracy and reliability of ProGRP measurements作者：Y Miyake·1994·被引用次数：264—Abstract.Gastrin-releasing peptide(GRP) is a specific and an actively secreted product of small cell lung carcinoma (SCLC) cells. Based on this.. These systems are instrumental in the precise quantification of Pro-gastrin releasing peptide levels, aiding in the crucial diagnosis and monitoring of patients.Overexpression of pro-gastrin releasing peptide promotes ... The development of new pro-gastrin releasing peptide assays contributes to the ongoing refinement of diagnostic capabilities.

In summary, progastrin-releasing peptide serves as a critical biomarker in clinical practice, primarily recognized for its role in the diagnosis and management of small cell lung cancer. Its function as a tumor marker, its relationship with gastrin, and its emerging significance in understanding various disease states underscore the importance of continued research and clinical application of this releasing peptide.Progastrin Releasing Peptide - an overview The understanding of pro-gastrin and its precursor form, Pro-gastrin, is integral to appreciating its diagnostic value.